This article describes the technique for ex vivo T cell stimulation to increase the intracellular concentration of cytokines such as interferon-gamma or IFN-gamma and tumor necrosis factor-alpha or TNF-alpha in the T cell. These cytokines mediate an effective anti-tumor response and can have a therapeutic role in the tumor.
Protocol
1. Digestion of pancreatic tumors Place the dissected pancreatic tumor, metastatic site tumors, or healthy pancreatic tissue in ice-cold PBS, and store on ice. Use forceps to transfer the tumor onto a Petri dish. Add 5.0 mL of digestion medium (2 mg/mL Collagenase, 0.025 mg/mL DNase RPMI) into a 50 mL tube; store on ice to prevent enzyme activity commencing. NOTE: This protocol uses Collagenase Type V, which has an activity of ≥1 units/mg FALGPA and > …
Açıklamalar
The authors have nothing to disclose.
Materials
70 μm pore-size cell strainer
Fisher Scientific
11597522
anti-CD107a PE (clone 1D4B)
Biolegend
121612
1:100 to culture media
Bovine Serum Albumin (BSA)
Sigma-Aldrich
A4503
Cell Stimulation Cocktail (500x) (phorbol 12-myristate 13-acetate (PMA) and ionomycin)
eBioscience
00-4970-03
x Final concentration PMA 0.081 μM, ionomycin 1.34 μM
THP1 Human Monocytic Leukemia Cells
ATCC
TIB-202
Collagenase Type V from Clostridium histolyticum
Sigma-Aldrich
C9263
2 mg/mL in media
Dimethyl sulphoxide (DMSO)
Sigma-Aldrich
D2650-100mL
DNase (Deoxyribonuclease I from bovine pancreas Type II-S) stock 10 mg/mL in 0.15 M NaCl
Sigma-Aldrich
D4513
Final concentration in digestion media 0.025 mg/mL
Foetal calf-serum (FCS)
GE Healthcare
A15-104
10% in RPMI
Hamilton syringe 700 series, 25 μL volume, 22s gauge needle bevel tip
Fisher Scientific
10100332
Penicillin/streptomycin
PAA
15140122
100 units/mL Penicillin, 100 μg/mL Streptomycin
Protein transport inhibitor cocktail (500x) (brefeldin A and monesin)
eBioscience
00-4980-03
1x Final concentration Brefeldin A 10.6 μM, monensin 2 μM
Ex Vivo T Cell Stimulation in the Pancreatic Tumor: A Method to Increase Cytokine Production in T Cells. J. Vis. Exp. (Pending Publication), e20306, doi: (2023).